Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride may help shrink prostate cancer tumors.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride helps reduce blood vessel growth in diabetic rat kidneys.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

CT scans can find serious prostate cancer even when PSA levels are low.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Early hair loss may indicate prostate issues.

Finasteride affects prostate weights and pituitary activity differently with age.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Finasteride reduces prostate size and PSA levels in young patients.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

New Finasteride conjugate improves prostate treatment and vital signs in rats.